SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-07-000008
Filing Date
2007-01-05
Accepted
2007-01-05 15:50:34
Documents
3
Period of Report
2007-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 KING PURCHASE AGREEMENT AND AMENDMENT NO. 1 ligand0105078k.txt 8-K 7216
2 AMENDMENT NO.1 TO PURCHASE AGREEMENT ex2-1.txt EX-2 7601
3 SIDE LETTER TO PURCHASE AGREEMENT ex10-1.txt EX-10 3296
  Complete submission text file 0000886163-07-000008.txt   19637
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 07513868
SIC: 2834 Pharmaceutical Preparations